Concepedia

Nacef Bahri

NB

6

Publications

215

Citations

6

H-Index

2015

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Zhejiang Sci-Tech University

Dana-Farber Cancer Institute

Nacef Bahri is an author at Brigham and Women's Hospital specializing in radiation oncology, medicine, and pathology.

Top concepts

Publications per year

2015–2021

6

Publications

6

MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation

Inga‐Marie Schaefer, Yuexiang Wang, Cher‐Wei Liang et al. · Nature Communications · 2017 · 66 citations · Full text

<i>CDKN2A</i>/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Grant Eilers, Jeffrey T. Czaplinski, Mark Mayeda et al. · Molecular Cancer Therapeutics · 2015 · 51 citations · Full text

, , +15

YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways

Wen‐Bin Ou, Meijun Z. Lundberg, Shuihao Zhu et al. · Oncogenesis · 2021 · 33 citations · Full text

Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor

Ivan J. Stojanov, Adrián Mariño‐Enríquez, Nacef Bahri et al. · Head and Neck Pathology · 2018 · 26 citations

, , +6

AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression

Wei Song, Hao Wang, Minmin Lu et al. · Cancers · 2020 · 20 citations · Full text

Rows per page

1–5 of 6